Kevin W Eliceiri Selected Research

Collagen

11/2021	Mammary collagen architecture and its association with mammographic density and lesion severity among women undergoing image-guided breast biopsy.
1/2021	Navigating the Collagen Jungle: The Biomedical Potential of Fiber Organization in Cancer.
1/2021	Collagen Organization in Relation to Ductal Carcinoma In Situ Pathology and Outcomes.
1/2021	Modeling early thermal injury using an ex vivo human skin model of contact burns.
11/2020	Optical imaging of collagen fiber damage to assess thermally injured human skin.
1/2020	Fibrillar Collagen Quantification With Curvelet Transform Based Computational Methods.
11/2019	Optimization of interstrand interactions enables burn detection with a collagen-mimetic peptide.
10/2019	Quantitative Histopathology of Stained Tissues using Color Spatial Light Interference Microscopy (cSLIM).
5/2019	Collagen organization of renal cell carcinoma differs between low and high grade tumors.
1/2019	Mammographic density: intersection of advocacy, science, and clinical practice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kevin W Eliceiri Research Topics

Disease

55	Neoplasms (Cancer) 11/2021 - 12/2006
29	Breast Neoplasms (Breast Cancer) 11/2021 - 12/2006
9	Neoplasm Metastasis (Metastasis) 01/2017 - 04/2008
7	Wounds and Injuries (Trauma) 01/2021 - 06/2015
6	Fibrosis (Cirrhosis) 01/2021 - 01/2014
5	Carcinogenesis 01/2016 - 02/2005
4	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 04/2011
4	Burns 01/2021 - 01/2018
4	Pancreatic Neoplasms (Pancreatic Cancer) 11/2020 - 01/2016
4	Inflammation (Inflammations) 01/2019 - 06/2015
3	Disease Progression 01/2021 - 02/2016
3	Adenocarcinoma 12/2016 - 11/2015
2	Hypoxia (Hypoxemia) 04/2021 - 02/2015
2	Premature Birth (Birth, Premature) 01/2021 - 03/2013
2	Necrosis 01/2021 - 01/2018
2	Retinal Vein Occlusion 01/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2018 - 05/2013
2	Ductal Carcinoma 01/2018 - 01/2014
2	Glioblastoma (Glioblastoma Multiforme) 06/2017 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 10/2016
2	Carcinoma in Situ 03/2007 - 02/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Breast Diseases (Breast Disease) 11/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Macular Edema 01/2020
1	Sarcopenia 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Neuroma 12/2017
1	Brain Neoplasms (Brain Tumor) 06/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 02/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Asthma (Bronchial Asthma) 01/2017
1	Osteogenesis Imperfecta (Lobstein Disease) 01/2017
1	Circulating Neoplastic Cells 01/2017
1	Squamous Cell Carcinoma of Head and Neck 12/2016
1	Sclerosis 11/2016
1	Colorectal Neoplasms (Colorectal Cancer) 02/2016
1	Pulmonary Hypertension 02/2016
1	Type 2B Charcot-Marie-Tooth disease 01/2016

Drug/Important Bio-Agent (IBA)

56	CollagenIBA 11/2021 - 12/2006
10	Fibrillar CollagensIBA 01/2021 - 08/2011
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2005
8	NAD (NADH)IBA 01/2016 - 10/2005
7	Biomarkers (Surrogate Marker)IBA 04/2021 - 11/2009
6	Flavin-Adenine Dinucleotide (FAD)IBA 01/2016 - 12/2007
5	Glucose (Dextrose)FDA LinkGeneric 04/2021 - 01/2015
4	ProlactinIBA 01/2017 - 05/2013
3	Biological ProductsIBA 01/2022 - 11/2015
3	Estrogens (Estrogen)FDA Link 07/2016 - 03/2011
3	Phenobarbital (Luminal)FDA Link 01/2015 - 05/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 04/2021 - 01/2016
2	Complement System Proteins (Complement)IBA 01/2021 - 05/2019
2	Peptides (Polypeptides)IBA 11/2019 - 04/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018 - 08/2011
2	Estrogen ReceptorsIBA 01/2018 - 07/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 03/2011
2	MicellesIBA 02/2017 - 04/2015
2	Green Fluorescent ProteinsIBA 01/2017 - 12/2008
2	Estrogen Receptor alphaIBA 01/2017 - 01/2015
2	IntegrinsIBA 01/2017 - 04/2015
2	Potassium CyanideIBA 01/2016 - 10/2005
2	Discoidin Domain Receptor 2IBA 01/2016 - 06/2013
2	Pharmaceutical PreparationsIBA 04/2015 - 02/2015
2	GelsIBA 08/2011 - 04/2008
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 06/2021
1	Blood Glucose (Blood Sugar)IBA 04/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2021
1	Lactate Dehydrogenase 5IBA 04/2021
1	Pyruvic Acid (Pyruvate)IBA 04/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Valsartan (Vals)FDA Link 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	EnzymesIBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Protein-Arginine DeiminasesIBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	CalciumIBA 01/2020
1	Coloring Agents (Dyes)IBA 10/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	VimentinIBA 01/2018
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	TenascinIBA 01/2018
1	Collagen Type I (Type I Collagen)IBA 01/2018
1	Syndecan-1 (Syndecan 1)IBA 01/2018
1	Janus KinasesIBA 01/2017
1	sharpinIBA 01/2017
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Ether (Diethyl Ether)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 12/2016

Therapy/Procedure

6	Lasers (Laser) 02/2016 - 02/2005
4	Therapeutics 01/2017 - 11/2009
2	Caloric Restriction 01/2020 - 01/2017
1	Bioreactors (Bioreactor) 01/2019
1	Combination Drug Therapy (Combination Chemotherapy) 02/2017
1	Photochemotherapy (Photodynamic Therapy) 02/2017
1	Transplantation 01/2017